Eli Lilly
Trade Eli Lilly 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About LLY
Eli Lilly & Co. engages in the discovery, development, manufacture, and sale of pharmaceutical products. The firm's products include diabetes, oncology, immunology, neuroscience, and other products and therapies.
LLY Key Statistics
Stock Snapshot
With a market cap of 878.9B, Eli Lilly(LLY) trades at $930.23. The stock has a price-to-earnings ratio of 40.93 and currently yields dividends of 66.3%.
During the trading session on 2026-04-13, Eli Lilly(LLY) shares reached a daily high of $945.90 and a low of $927.17. At a current price of $930.23, the stock is +0.3% higher than the low and still -1.7% under the high.
Trading volume for Eli Lilly(LLY) stock has reached 1.21M, versus its average volume of 2.9M.
Over the past 52 weeks, Eli Lilly(LLY) stock has traded between a high of $1,133.95 and a low of $623.78.
Over the past 52 weeks, Eli Lilly(LLY) stock has traded between a high of $1,133.95 and a low of $623.78.
LLY News
Eli Lilly (LLY) announced that it has made significant progress with a new leukemia drug, giving its stock a shot in the arm as a result. Unlock hedge fund-lev...
Key Points A weight loss pill would help Eli Lilly reach a broader segment of the population. Its existing GLP-1 drugs have already been generating billions i...
...
Analyst ratings
83%
of 35 ratingsMore LLY News
Eli Lilly and Co. (NYSE:LLY) shares were little changed in Monday’s premarket session. The U.S. drug giant shared results from the Phase 3 BRUIN CLL-322 trial...
Eli Lilly (LLY) announced topline results from the Phase 3 BRUIN CLL-322 trial of Jaypirca, a non-covalent Bruton tyrosine kinase inhibitor, plus venetoclax and...
Eli Lilly (NYSE:LLY) is seeing rapid market share declines in India for its GLP-1 obesity drugs as generic competitors expand following patent expirations. At...
Eli Lilly vs. Novo Nordisk: The Obesity Drug Race Has a New Leader By Vandita Jadeja Published Apr 10, 12:09PM EDT Quick Read Eli Lilly (LLY) reported Q4 reve...
Who Benefits From Amazon Pharmacy Stocking Eli Lilly’s New Weight Loss Pill By Trey Thoelcke Published Apr 10, 8:25AM EDT Quick Read Amazon (AMZN) has made a...
Eli Lilly's oral GLP-1 obesity pill Foundayo is beginning a broad U.S. launch via Amazon Pharmacy, GoodRx, Ro, Weight Watchers, and LillyDirect. The rollout us...
Taking GLP-1s once meant injecting a shot with a monthly price tag of $1,000. Today, patients interested in the wildly popular weight-loss drugs can choose amon...
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.